Latest debt-to-equity ratio
Avalyn Pharma Debt-to-equity ratio
Direct answer
Avalyn Pharma's debt-to-equity ratio is 4.3%.
The verified market snapshot reports 4.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Avalyn Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.3%